Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insmed (INSM) Total Current Liabilities (2016 - 2026)

Insmed's Total Current Liabilities history spans 17 years, with the latest figure at $361.0 million for Q1 2026.

  • Quarterly Total Current Liabilities rose 50.9% to $361.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $361.0 million through Mar 2026, up 50.9% year-over-year, with the annual reading at $468.9 million for FY2025, 57.59% up from the prior year.
  • Total Current Liabilities came in at $361.0 million for Q1 2026, down from $468.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $524.2 million in Q2 2024 to a low of $113.8 million in Q2 2022.
  • The 5-year median for Total Current Liabilities is $239.2 million (2025), against an average of $275.4 million.
  • Year-over-year, Total Current Liabilities soared 156.61% in 2024 and then plummeted 43.16% in 2025.
  • Insmed's Total Current Liabilities stood at $190.2 million in 2022, then increased by 18.6% to $225.6 million in 2023, then soared by 31.87% to $297.5 million in 2024, then surged by 57.59% to $468.9 million in 2025, then decreased by 23.01% to $361.0 million in 2026.
  • Per Business Quant, the three most recent readings for INSM's Total Current Liabilities are $361.0 million (Q1 2026), $468.9 million (Q4 2025), and $417.2 million (Q3 2025).